Brief: Xortx Announces Pre-Phase 3 Meeting Request With Us Food And Drug Administration (FDA)
07/07/2022 13:03
July 7 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX ANNOUNCES PRE-PHASE 3 MEETING REQUEST WITH US FOOD AND DRUG
ADMINISTRATION
(FDA)
* XORTX THERAPEUTICS INC - MEETING IS EXPECTED TO BE HELD IN APPROXIMATELY
70 DAYS
FROM TODAY
Source text for Eikon: ID:nGNX32pHJk
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering